Shows
She Thinks Big®How to Onboard New Hires & Address or Fire Problematic Ones with Cherie IhnenIs your onboarding process a smooth sailing experience for new people you bring into your company? You can get tripped up when hiring (or firing) someone and discover that you need the help of a professional.My guest, Cherie Ihnen is a Human Resources consultant who works with different size businesses. She has approximately 20 years of experience in HR leadership, and she’s seen many of the mistakes CEOs make that lead to performance issues and ill-fitting team members who need to be let go.In this episode of the She Thinks Big podcast, you’ll l...
2024-10-2936 min
BioCastEP. 11: Biomarketing faz 10 anos!Neste episódio especial do BioCast, vamos falar sobre o aniversário de 10 anos da Biomarketing. Vamos relembrar os melhores momentos da nossa trajetória, lições aprendidas e cases de sucesso. Participam deste episódio os sócios-diretores da Biomarketing Camila Macedo Soares, Coriolano Xavier, Doly Ribeiro e José Luiz Tejon.
2024-08-1243 min
PAPO FORTEEp. 1 - O Brasil vai dobrar seu agro de tamanho até 2035Neste primeiro episódio do nosso canal vamos conversar sobre o agro brasileiro, sua meta de dobrar seu agro de tamanho até 2035 e a importância dos fertilizantes no atingimento dessa meta, além de debatermos conceitos importantes que marcam o agro nacional, como o de agribusiness e o de agrocidadania. O convidado de hoje é José Luis Tejon professor, doutor em educação, jornalista, publicitário, escritor e sócio-diretor da Biomarketing,
2024-04-3030 min
Minuto Agro – É questionando que evoluímosMinuto Agro | Ep 29: Aprendizados de 2023 e o que levar para 2024Neste episódio, mergulharemos nos aprendizados cruciais que o agronegócio brasileiro conquistou em 2023 e discutiremos como estes aprendizados estão moldando as estratégias para 2024. O convidado de hoje é um mestre no agronegócio. Ele é professor, doutor em educação, jornalista, publicitário, escritor e sócio-diretor da Biomarketing - José Luiz Tejon.
2024-02-1525 min
Minuto Agro – É questionando que evoluímosMinuto Agro | Ep 29: Aprendizados de 2023 e o que levar para 2024Neste episódio, mergulharemos nos aprendizados cruciais que o agronegócio brasileiro conquistou em 2023 e discutiremos como estes aprendizados estão moldando as estratégias para 2024. O convidado de hoje é um mestre no agronegócio. Ele é professor, doutor em educação, jornalista, publicitário, escritor e sócio-diretor da Biomarketing - José Luiz Tejon.
2024-02-1525 min
ACADEMIA DO AGROO Poder do IncômodoJosé Luiz Tejon Megido nasceu em Santos, em 1952. Filho adotivo, não conheceu seus pais biológicos. Seu pai morreu nos cárceres da ditadura franquista, na Espanha. Já sua mãe, a espanhola Benigna Tejon Megido, veio a falecer na Argentina, onde o deixou para adoção com o casal de imigrantes: Antônio Alves (português) e Rosalinda Hoffmann (alemã). Aos quatro anos de idade, Tejon sofreu uma queimadura de 3º grau total da face e passou 14 anos semi-internado em hospitais públicos, onde iniciou seus estudos numa escola para crianças especiais da Santa Casa de Santos....
2023-05-021h 00Rede Rural de PodcastsO Poder do IncômodoJosé Luiz Tejon Megido nasceu em Santos, em 1952. Filho adotivo, não conheceu seus pais biológicos. Seu pai morreu nos cárceres da ditadura franquista, na Espanha. Já sua mãe, a espanhola Benigna Tejon Megido, veio a falecer na Argentina, onde o deixou para adoção com o casal de imigrantes: Antônio Alves (português) e Rosalinda Hoffmann (alemã). Aos quatro anos de idade, Tejon sofreu uma queimadura de 3º grau total da face e passou 14 anos semi-internado em hospitais públicos, onde iniciou seus estudos numa escola para crianças especiais da Santa Casa de Santos....
2023-05-021h 00
Rare in Common: the podcastEpisode 29 – “It’s not going to control my life:” Adapting to life with LEMSIn December 2019, Tescha left her job of 16 years as a physician’s assistant in the emergency room after facing difficulties with her recently diagnosed Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disease that attacks the connection between nerves and muscle cells. While living at home, Tescha saw an opportunity to reinvent herself with the support of her family and her newly discovered love of woodworking. Even though LEMS was a part of her life, she proved it would not control her life.
2022-04-2821 minBioCastEp 1: Criando marcas fortes e potencializando valor do agronegócio - Com Camila Macedo, Coriolano Xavier, Doly Ribeiro e José Luiz TejonNa estreia do BioCast, recebemos para um bate-papo super descontraído os quatro sócios da Biomarketing: Camila Macedo Soares, que também é apresentadora do canal, Coriolano Xavier, Doly Ribeiro e José Luiz Tejon. Saiba como nasceu a agência do agro e conheça os bastidores do Time.
2022-04-1434 min
Instituto MilleniumJosé Luiz Tejon Megido comenta previsões de boa safra para o agro brasileiro🚜 Apesar da crise econômica, o agronegócio segue crescendo e prevê safra de grãos recorde em 2022. O sócio diretor da Biomarketing, José Luiz Tejon Megido, explica em entrevista ao Imil quais os principais fatores que possibilitam esses bons números.
💻 Confira: https://www.institutomillenium.org.br/previsao-de-safra-recorde-de-graos-em-2022-movimenta-economia/
2021-11-1714 min
Instituto MilleniumJosé Luiz Tejon Megido comenta previsões de boa safra para o agro brasileiro🚜 Apesar da crise econômica, o agronegócio segue crescendo e prevê safra de grãos recorde em 2022. O sócio diretor da Biomarketing, José Luiz Tejon Megido, explica em entrevista ao Imil quais os principais fatores que possibilitam esses bons números.
💻 Confira: https://www.institutomillenium.org.br/previsao-de-safra-recorde-de-graos-em-2022-movimenta-economia/
2021-11-1714 min
Sala de Negócios#019 Os caminhos para aumentar o PIB do Brasil | José Luiz Tejon (Biomarketing)Um dos desafios para o Brasil é fazer o PIB crescer e alcançar o patamar de protagonista no cenário econômico mundial. Não se trata apenas de uma missão do governo, mas sim da sociedade civil organizada. Existem caminhos para isso, como o cooperativismo e o próprio agronegócio. Apresentação: Cassio Politi e Pedro Lopes. Convidado: José Luiz Tejon (sócio-diretor da Biomarketing). Perfil do convidado no LinkedIn: https://www.linkedin.com/in/luiztejon/. Site do convidado: https://tejon.com.br/. Anote algumas outras referências citadas no podcast. PIB do Brasil: https://www.ibge.gov.br/explic
2021-10-0537 min
Minuto Agro – É questionando que evoluímosMinuto Agro | Ep 1: Cenário do agronegócio no Brasil e a evolução de práticas sustentáveis e o uso de defensivos biológicosNeste primeiro episódio, vamos falar sobre o agronegócio e os biológicos no Brasil. Participam deste episódio Dario Maffei, CEO LATAM da Indigo, além de José Luiz Tejon, jornalista, publicitário, professor e palestrante, que é comentarista da Rádio Eldorado, colunista do Estadão online e sócio-diretor da Biomarketing, agência de comunicação especializada em Agronegócio. Eles vão falar um pouco sobre as principais dúvidas sobre o assunto.
2021-08-0442 minMinuto Agro – É questionando que evoluímosMinuto Agro | Ep 1: Cenário do agronegócio no Brasil e a evolução de práticas sustentáveis e o uso de defensivos biológicosNeste primeiro episódio, vamos falar sobre o agronegócio e os biológicos no Brasil. Participam deste episódio Dario Maffei, CEO LATAM da Indigo, além de José Luiz Tejon, jornalista, publicitário, professor e palestrante, que é comentarista da Rádio Eldorado, colunista do Estadão online e sócio-diretor da Biomarketing, agência de comunicação especializada em Agronegócio. Eles vão falar um pouco sobre as principais dúvidas sobre o assunto.
2021-08-0442 min
Rare in Common: the podcastEpisode 28 – #RareDiseaseTruth: how a hashtag is changing the conversation this Rare Disease DayApproaching Rare Disease Day 2021, Neena Nizar, EdD, felt frustrated with the usual conversation around living with rare. Instead, she decided to start a different dialogue, sharing the hard truths of her condition.
What followed was an outpouring of global support, with individuals from many rare disease communities coming together to share their stories with the hashtag #RareDiseaseTruth. In less than 2 weeks, the hashtag reached nearly 2 million people, generating 7000 interactions and 5000 shares.
In addition to celebrating their strength this Rare Disease Day, the hashtag has given patients, caregivers, and leaders the chance to be vulnerable—and discover common truths that tie th...
2021-02-2534 min
Rare in Common: the podcastEpisode 27 – “It’s working time”: building Sophie’s NeighborhoodIn March 2020, after a year of battling what was assumed to be arthritis, 3-year-old Sophie Rosenberg was diagnosed with multicentric carpotarsal osteolysis (MCTO), a rare skeletal dysplasia. In spite of their initial shock, her parents Lauren and Hosea immediately tapped into their entrepreneurial roots, creating Sophie’s Neighborhood, an advocacy organization dedicated to funding research for MCTO treatments. They now find themselves in the unfamiliar world of rare disease advocacy, fighting to change their daughter’s future.
And they need your help. Sophie’s Neighborhood is holding their next fundraiser on August 15, 2020.
2020-07-3034 min
Rare in Common: the podcastEpisode 26 – From diagnosis to network director—living with XLHDiagnosed with X-linked hypophosphatemia (XLH), Susan has faced the challenges of living with this rare disease to become an advocate of the community and an influential force behind the XLH Network. The global community recently celebrated the second annual XLH Awareness Day on June 23, 2020.
This episode is brought to you by Ultragenyx.
2020-06-2530 min
Rare in Common: the podcastEpisode 25 – What does COVID-19 mean for the rare disease community?As a global community, we’re living through unprecedented times. But what does COVID-19 mean for people living with rare diseases? Neena Nizar and Seth Rotberg are rare disease advocates, both living with rare diseases themselves, and are here to provide some insight. In this episode, they discuss the impact of the pandemic, both in their present-day lives and for the future of the entire rare community.
2020-04-0935 min
Rare in Common: the podcastEpisode 24 – The promise of genetic testing in rarePatients diagnosed with rare diseases likely have a lot of questions. Luckily, Joe Alaimo, our guest on this episode of the American College of Medical Genetics and Genomics (ACMG) series, can help answer them. Hear from Alaimo as he talks about the importance of genetic research in the rare disease space and advocates for patient education to promote disease understanding.
2020-03-2627 min
Rare in Common: the podcastEpisode 23 – Breaking through with interactive education in rare diseaseWhen it comes to understanding rare disease, education is the first step. In this installment of the American College of Medical Genetics and Genomics (ACMG) series, our guest is Debra Regier, the director of genetics education at Children’s National Medical Center in Washington, DC. Listen as she discusses her methods in making education more effective, as well as the importance of interactive learning in rare disease.
2020-02-2724 min
Rare in Common: the podcastEpisode 22 – Misdiagnosed: The importance of genetic testingA diagnosis is supposed to bring patients answers, but what happens if that diagnosis is wrong? Meet Susie Perkowitz, a patient living with a rare form of diabetes who faces blindness due to 3 years of misdiagnoses and incorrect treatment. Listen as she and Toni Pollin, a geneticist focusing on monogenic diabetes research, explain the importance of a correct diagnosis and how advocacy, working together, and genetic testing are paramount to finding answers for patients.
2020-01-3026 min
Rare in Common: the podcastEpisode 21 – From broad questions to exact answersWith gene therapies on the horizon, a diagnosis is more important than ever. In this installment of the American College of Medical Genetics and Genomics (ACMG) series, our guest Melanie O’Leary discusses the Rare Genomes Project and the goal to use whole genome sequencing technology to find answers for those with undiagnosed genetic diseases. Listen as she explains why broad is better in finding a diagnosis and the importance of partnerships with patients.
2019-12-1919 min
Rare in Common: the podcastEpisode 20 – Taking back life by tackling diagnosisIn the world of rare disease, it can feel impossible to find a diagnosis, let alone a treatment. Onno Faber explains how his interest in science helped him when was diagnosed with a rare disease called neurofibromatosis type 2 (NF2). Listen as he talks about the importance of patient involvement and his dreams for the future of rare disease.
2019-11-2118 min
Rare in Common: the podcastEpisode 19 — Exploring transgenics—the forefront of genetic advancement in rareDid you know that there are benefits to studying human genetic variants in worms or fish? In this fascinating chat recorded at the American College of Medical Genetics and Genomics (ACMG) annual meeting, Shula Jaron explains how transgenics give scientists a simpler way to study human disease genes and mutations in live organisms. You may be surprised to learn that worms and zebrafish play an important role in discoveries in rare.
2019-07-1819 min
Rare in Common: the podcastEpisode 18 — Connecting the dots in the network of rareIn this episode recorded at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, hear from 2 experts in the field of genetics. First, Dr. George Diaz discusses his role as a medical geneticist and pediatrician, the value of connecting families affected by rare diseases, and the impact technological advancements have made in his field. Next, Dr. Katy Phelan shares highlights of her career as a laboratory geneticist—including her discovery of a rare deletion syndrome. She explains why when patients connect, it helps their families and improves her research and understanding of the disease.
2019-06-2034 min
Rare in Common: the podcastEpisode 17 — The hope that comes with a name: the power of a diagnosisFor this third installment of the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting series, we sat down with Kim LeBlanc of the Undiagnosed Diseases Network (UDN). She walks us through how the UDN helps patients find answers, a diagnosis, and a community, as well as the hope a diagnosis can provide for those living with a rare disease. Listen as Kim explores the journey to diagnosis through UDN, resources and organizations for undiagnosed patients, and the role of genetic counselors in the rare space.
2019-05-2325 min
Rare in Common: the podcastEpisode 16 — Voices of ACMG: On the floor at the 2019 annual meetingIn this special episode, join the Rare in Common team on the floor at the American College of Medical Genetics and Genomics (ACMG) annual meeting in Seattle. As the team walked around the conference, Andra had the opportunity to chat with members of the genetics community in attendance, from geneticists to genetic counselors to advocates. After speaking with the guests, it’s clear there is a positive outlook for the rare community with the help of advancements in genetics.
2019-05-0924 min
Rare in Common: the podcastEpisode 15 — The A, T, G, and C’s of genes: exploring genetics with Dr. Anthony GreggThis episode is the first in a special series recorded live at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting in Seattle. We had the honor of speaking with Dr. Anthony Gregg, the incoming president of ACMG, to get his perspective on what medical genetics brings to the practice of medicine. Dr. Gregg shares the benefits of getting rare genetic disorders diagnosed early, and the many ways in which this knowledge can help families plan and prepare. Dr. Gregg also provides a fun and interesting lesson in genetics that everyone can understand.
2019-04-2528 min
The ROI PodcastHow can we adapt to the "working remotely" trend? | Ep. 87Forbes.com released an article in December of 2018 that states, "Remote work is no longer a privilege. It’s becoming the standard operating mode for at least 50% of the U.S. population." A staggering trend that’s continuing to grow. With organizations adapting to or fighting against this movement – the question is, how do we address it? On this episode, we’re sitting down with the founder of VMS BioMarketing Neal Rothermel, who shares how his company makes working remotely, successful.
----
Do you have a question? Looking to get help on a business decision? Know a great guest for our show...
2019-04-0119 min
Rare in Common: the podcastEpisode 14 — “Beautifully heartbreaking”: one mom’s rare and incredible journeyFrom navigating her son Case’s rare diagnosis with the help of her own mother (and a medical diagnosis television show) to being honored at a global summit meeting for patient advocates almost a decade later, Melissa Hogan’s story is raw and riveting. She describes the reality of her son living with mucopolysaccaridosis II, or Hunter syndrome, as “beautifully heartbreaking”—
a sentiment that rings true for so many parents raising children with rare diseases.
2019-03-2827 min
Rare in Common: the podcastEpisode 13 — Rare Disease Day: Looking back. Forging aheadRare Disease Day marks 1 year of creating Rare in Common podcasts! In honor of this special day, which is celebrated by the rare disease community around the world, we’ve created an episode that highlights some familiar voices from past podcasts and even puts host Andra Stratton in the “guest seat” to answer some important questions.
At the 2018 Global Genes RARE Patient Advocacy Summit, Andra was inspired by the 3 questions posed to everyone in attendance by keynote speaker Rachel Callander, TedX presenter and author of the award-winning Super Power Baby Project. She explores those questions with our guests and offers her pe...
2019-02-2818 min
Rare in Common: the podcastEpisode 12 — When all the stars align in the fight against ALLWhen Eve Pallang felt a pain in her ribcage, she first brushed it off as muscle soreness from shoveling snow. The pain continued to spread so she went for an X-ray. The results were normal, but, fortunately, a doctor at the hospital advised her to go for more tests. Ultimately, she received the earth-shattering news that she had acute lymphoblastic leukemia (ALL).
Facing her diagnosis—and all that followed—with the support of her husband and family was critical for Eve. But she but no idea at the start of her journey to remission how being in the right place at t...
2019-01-2438 min
Rare in Common: the podcastEpisode 11 — “I got here because I asked for help”: coming together in rareThis episode is the third in a special series recorded live at the 7th annual Global Genes RARE Patient Advocacy Summit, the largest worldwide gathering of rare disease patients, advocates, and thought leaders.
When Luke Rosen’s daughter Susannah was diagnosed with a rare, neurodegenerative disease called KIF1A-associated neurological disorder (KAND) in 2016, he quickly learned there was a lack of information and resources for families like his. His desire to be there for his family and search for a treatment for KAND prompted him to leave his acting career behind and forge a new path.
Two years later, as th...
2018-12-2020 min
Rare in Common: the podcastEpisode 10 — When a rare disease treatment fails approval, what happens next?This episode is the second in a special series recorded live at the 7th annual Global Genes RARE Patient Advocacy Summit—and an important follow-up to Episode 4, “Taking on Rare as a Family,” in which Justin Hastings spoke about living with familial chylomicronemia syndrome (FCS).
In August 2018, Waylivra® (volanesorsen sodium) was slated to receive final approval from the Food and Drug Administration (FDA) and become the first-ever therapy specifically for the treatment of FCS. Instead, Akcea Therapeutics, the company that makes Waylivra, received a complete response letter (CRL) from the FDA, rejecting approval of the drug, causing a wave of surpris...
2018-11-2915 min
Rare in Common: the podcastEpisode 9 — From physician to CEO; always a passion for rareRare disease is a specialized field. You may wonder how some doctors or executives choose this career path. While Dr. Ed Kaye started out caring for pediatric patients living with rare diseases, he moved into key leadership roles at biopharma companies that develop groundbreaking therapies to treat them. Dr. Kaye shares his unique industry perspective and the important things he has learned from both his successes and failures along the way.
2018-11-1533 min
Rare in Common: the podcastEpisode 8 — On location: Global Genes RARE Patient Advocacy SummitThis episode is the first in a special series recorded live at the 7th annual Global Genes RARE Patient Advocacy Summit—the largest worldwide gathering of rare disease patients, advocates, and thought leaders.
First, Angie Rowe, Interim Executive Director of Global Genes, reflects on how exciting it is to spend time at the conference after all of her team’s hard work in bringing it to life. She also talks about how the summit inspires and empowers attendees, newcomers and veterans alike.
Next, we hear from 2 first-time summit attendees, Christine Von Raesfeld, who was diagnosed with a bleeding disorder called thro...
2018-11-0122 min
Rare in Common: the podcastEpisode 7 — Blood brothers and sisters: the bond of hemophilia AEpisode 7 — Blood brothers and sisters: the bond of hemophilia A by Cambridge BioMarketing
2018-10-0427 min
Rare in Common: the podcastEpisode 6 — Two rare: fighting Marfan and Ehlers-DanlosEpisode 6 — Two rare: fighting Marfan and Ehlers-Danlos by Cambridge BioMarketing
2018-08-3036 min
Rare in Common: the podcastEpisode 5 — The power of siblinghood in rareGain a deeper understanding of Sturge-Weber syndrome by seeing it through the eyes of 13-year-old Olivia, whose younger brother, Jameson, has the rare neurological disorder. As they balance fun-filled times with the realities of living with a rare disease, these siblings share a bond that’s as powerful and pure as it gets.
2018-07-2022 min
Rare in Common: the podcastEpisode 4 — Taking on rare as a familyAfter a decade of frequent bouts of acute pancreatitis, including 30 hospitalizations and many painful episodes at home, it was Justin’s wife Naomi who helped lead their physician to a diagnosis of familial chylomicronemia syndrome (FCS).
2018-06-2829 min
Rare in Common: the podcastEpisode 3 – Ehlers-Danlos and rare artAfter years of misdiagnosis by physicians, Patty diagnosed her daughter’s Ehlers-Danlos syndrome through her own independent research. Since then, she’s worked tirelessly to advocate for the rare disease community, inspiring truly rare artwork along the way.
2018-02-2846 min
Rare in Common: the podcastEpisode 2 – On trialWhen two of Jenn’s children were diagnosed with Duchenne Muscular Dystrophy (DMD), it changed her life. Since then, she’s fought for access to clinical trials and new treatments and inspired others to join the cause along the way.
2018-02-2822 min
Rare in Common: the podcastEpisode 1 – Hanging out with zebrasThose living with rare diseases refer to themselves as “zebras”. Janis is no exception. Her son Luke has a genetic mutation so rare it’s never been reported before. As her family works toward a diagnosis, she finds support among other zebras like her.
2018-02-2838 min
Life Science Marketing RadioHow to Have a Conversation with Customers Using Marketing AutomationIn the first part of this series, I spoke with Guy Page of Pacific Biomarketing about how life science companies can take advantage of marketing automation to improve the buying experience for their …
2015-10-0537 min
cc: Life Science PodcastHow to Have a Conversation with Customers Using Marketing AutomationIn the first part of this series, I spoke with Guy Page of Pacific Biomarketing about how life science companies can take advantage of marketing automation to improve the buying experience for their … This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com
2015-10-0537 minLife Science Marketing RadioHow to Have a Conversation with Customers Using Marketing AutomationIn the first part of this series, I spoke with Guy Page of Pacific Biomarketing about how life science companies can take advantage of marketing automation to improve the buying experience for their … This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com
2015-10-0537 min